U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Substance Class Protein
Created
by admin
on Sat Dec 16 16:23:10 UTC 2023
Edited
by admin
on Sat Dec 16 16:23:10 UTC 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
1JQS135EYN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Oxytocin
EP   GREEN BOOK   HSDB   INN   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INN  
Official Name English
SYNTOCINON
Brand Name English
OXYTOCIN [USP MONOGRAPH]
Common Name English
GLYCINAMIDE, L-CYSTEINYL-L-TYROSYL-L-ISOLEUCYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LEUCYL-, CYCLIC (1->6)-DISULFIDE
Common Name English
PITOCIN
Brand Name English
OXYTOCIN [USP-RS]
Common Name English
UTERACON
Common Name English
TNX-1900
Code English
OXYTOCIN [VANDF]
Common Name English
OXYTOCIN [USP IMPURITY]
Common Name English
OXYTOCIN [WHO-IP]
Common Name English
ALPHA-HYPOPHAMINE [WHO-IP]
Common Name English
TTA-121
Code English
OXYTOCINUM [WHO-IP LATIN]
Common Name English
oxytocin [INN]
Common Name English
OXYTOCIN [ORANGE BOOK]
Common Name English
OXYTOCIN [JAN]
Common Name English
OXYTOCIN [HSDB]
Common Name English
OXYTOCIN [MART.]
Common Name English
ENDOPITUITRINA
Common Name English
Oxytocin [WHO-DD]
Common Name English
OXYTOCIN [MI]
Common Name English
OXYTOCIN [GREEN BOOK]
Common Name English
TNX1900
Code English
INTERTOCINE S
Common Name English
Classification Tree Code System Code
NDF-RT N0000006473
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
NDF-RT N0000009705
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
WHO-VATC QG02AC90
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
FDA ORPHAN DRUG 453614
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
CFR 21 CFR 522.1680
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 22.1
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
NDF-RT N0000009705
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
NDF-RT N0000006473
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
FDA ORPHAN DRUG 864421
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
WHO-ATC G02AC01
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
WHO-VATC QH01BB02
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
NDF-RT N0000009705
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
WHO-VATC QG02AC01
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
LOINC 2718-5
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
EU-Orphan Drug EU/3/14/1302
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
FDA ORPHAN DRUG 582717
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
NDF-RT N0000175828
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
WHO-ATC H01BB02
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
LOINC 35415-9
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
Code System Code Type Description
CAS
50-56-6
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-048-4
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
EPA CompTox
DTXSID8048361
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
PUBCHEM
439302
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
FDA UNII
1JQS135EYN
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
INN
1480
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
DRUG CENTRAL
2042
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
WIKIPEDIA
OXYTOCIN
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
NCI_THESAURUS
C724
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
MERCK INDEX
m8348
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY Merck Index
RS_ITEM_NUM
1491300
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
WIKIPEDIA
Oxytocin (medication)
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
HSDB
2182
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
ChEMBL
CHEMBL395429
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
RXCUI
7824
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY RxNorm
LACTMED
Oxytocin
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
DAILYMED
1JQS135EYN
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
MESH
D010121
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
DRUG BANK
DB00107
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
CHEBI
7872
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
OXYTOCIN
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY Description: White or almost white powder. Solubility: Very soluble in water. It dissolves in dilute solutions of acetic acid and of ethanol. Category: Uterine-stimulating (Oxytocic). Storage: Oxytocin should be kept in an airtight container, protected from light, at a temperature of 2 ?C to 8 ?C or if sterile, in asterile, airtight, tamper-evident container. Labelling: The label states:- where applicable, that the substance is free from bacterial endotoxins,- where applicable, that the substance is sterile.Additional information: Oxytocin is hygroscopic. Definition: Oxytocin is a synthetic cyclic nonapeptide having the structure of the hormone produced by the posterior lobe of thepituitary gland that stimulates contraction of the uterus and milk ejection in receptive mammals. It is available in the freeze-dried form as an acetate. Oxytocin contains not less than 93.0% and not more than 103.0% of the peptide C43H66N12O12S2, calculated with reference tothe anhydrous, acetic acid-free substance.By convention, for the purpose of labelling oxytocin preparations, 1 mg of oxytocin peptide (C43H66N12O12S2) is equivalent to 600 IU of biological activity.
EVMPD
SUB09580MIG
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
SMS_ID
100000092397
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
IUPHAR
2174
Created by admin on Sat Dec 16 16:23:11 UTC 2023 , Edited by admin on Sat Dec 16 16:23:11 UTC 2023
PRIMARY
From To
1_1 1_6
Related Record Type Details
OXYTOCIN ACETATE
SALT/SOLVATE -> PARENT
OXYTOCIN RECEPTOR
TARGET -> AGONIST
VASOPRESSIN V1A RECEPTOR
TARGET -> AGONIST
Ki
VASOPRESSIN V1B RECEPTOR
TARGET->WEAK AGONIST
Ki
VASOPRESSIN V1A RECEPTOR
TARGET -> AGONIST
IC50
Related Record Type Details
Structure of (PGLU4,CYT6)OXYTOCIN 4-9
METABOLITE ACTIVE -> PARENT
Does not bind to Oxytocin Receptor but leads to significant social preference in the BALB/cByJ model, in a dose-dependent manner. The increased sociability was observed at both 24 h and 12 days following the end of a subchronic regimen with OT(4–9) (2.0 mg/kg).
Related Record Type Details
[4-glutamic acid]oxytocin
IMPURITY -> PARENT
Oxytocin parallel dimer
IMPURITY -> PARENT
[5-Aspartic acid]-oxytocin
IMPURITY -> PARENT
Oxytocin, 5-(3-cyano-L-alanine)-
IMPURITY -> PARENT
Oxytocin antiparallel dimer
IMPURITY -> PARENT
[3-leucine]oxytocin
IMPURITY -> PARENT
Oxytocin, N-acetyl-
IMPURITY -> PARENT
Related Record Type Details
Oxytocin
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
Biological Half-life PHARMACOKINETIC Elimination
PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966